Related Experiment Videos
Interferon-alpha inhibits cyclin E- and cyclin D1-dependent CDK-2 kinase activity associated with RB protein and E2F
1Department of Medicine, Pennsylvania State University College of Medicine, Hershey 17033.
Abstract:
The state of phosphorylation of retinoblastoma (RB) protein is regulated by CDK2 and CDC2 kinases. In the studies presented here, we have investigated the effect of interferon-alpha (IFN-alpha) on cyclin-dependent kinases in Daudi cells which were synchronized at different points of the cell cycle progression. We observed that the IFN-alpha enhances the expression of underphosphorylated RB protein in Daudi cells released from the G1/S, and this was closely associated with the inhibition of CDK2 kinase and not CDC2 kinase activity. The observed IFN-alpha-sensitive CDK2 kinase activity was dependent on Cyclin E and cyclin D1 but not on cyclin A and was physically associated with transcriptional factors: RB and E2F. In addition, treatment of G1/S Daudi cells with IFN-alpha also inhibited the ability of CDK2 enzyme to phosphorylate the RB protein in vitro. These results suggest possible involvement of cell cycle kinases in IFN-alpha action.
Insights
Interferon-alpha (IFN-alpha) inhibits CDK2 kinase activity, increasing underphosphorylated retinoblastoma (RB) protein levels in Daudi cells. This suggests cell cycle kinases are involved in IFN-alpha
Area of Science:
- Cell Biology
- Molecular Biology
- Virology
Background:
- Retinoblastoma (RB) protein phosphorylation is a key cell cycle regulator.
- Cyclin-dependent kinases (CDKs), including CDK2 and CDC2, control RB protein phosphorylation.
- Interferon-alpha (IFN-alpha) is a cytokine with diverse cellular effects.
Purpose of the Study:
- To investigate the effect of IFN-alpha on cyclin-dependent kinases.
- To determine the impact of IFN-alpha on RB protein phosphorylation and cell cycle progression.
- To elucidate the role of specific CDKs and cyclins in IFN-alpha's action.
Main Methods:
- Cell synchronization at different cell cycle phases (G1/S).
- Treatment of Daudi cells with IFN-alpha.
- Assays for CDK2 and CDC2 kinase activity.
- Western blot analysis for RB protein phosphorylation.
- In vitro kinase assays and co-immunoprecipitation.
Main Results:
- IFN-alpha enhanced underphosphorylated RB protein expression in cells released from G1/S.
- IFN-alpha inhibited CDK2 kinase activity, but not CDC2 kinase activity.
- IFN-alpha-sensitive CDK2 activity was dependent on Cyclin E and Cyclin D1, associated with RB and E2F.
- IFN-alpha inhibited CDK2's ability to phosphorylate RB protein in vitro.
Conclusions:
- Cell cycle kinases, particularly CDK2, are implicated in the mechanism of IFN-alpha action.
- IFN-alpha may modulate cell cycle progression through its effects on CDK2/RB pathway.
- These findings provide insights into the molecular targets of IFN-alpha in cellular regulation.